On Wednesday, in the course of current trade, Shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM), gained 0.37%, and is now trading at $24.47.
On April 30, Taiwan Semiconductor North America has moved its San Jose office to 2851 Junction Avenue, San Jose, Calif., to serve its customers better. TSMC (TWSE: 2330, NYSE: TSM), based in Hsinchu, Taiwan is the world’s largest dedicated semiconductor foundry with 2014 revenues topping $25.1 billion. About 69 percent of TSMC’s worldwide sales originate in North America.
Taiwan Semiconductor Manufacturing Company Limited engages in the computer-aided design, manufacture, packaging, testing, sale, and marketing of integrated circuits and other semiconductor devices.
During an Afternoon trade, Shares of The Interpublic Group of Companies, Inc. (NYSE:IPG), dipped -0.19%, and is now trading at $20.81.
Cadreon, the digital marketing services platform of IPG Mediabrands, declared that the company has reached a partnership with TubeMogul (TUBE), a leading enterprise software platform for video advertising, to build a custom advanced TV automation platform. The two companies will apply best-in-class technology from TubeMogul and data intelligence from Cadreon to jointly build an automation system to scale automated buying efforts in TV, creating a proprietary inventory-agnostic, demand-side platform for TV.
“This platform is wholly focused on our clients’ needs, rather than one specific media vendor. Recently, there’s no automated system to access TV inventory from multiple suppliers, and our clients will be the first to receive the benefits of automation for this part of the market,” said Henry Tajer, Global CEO of IPG Mediabrands. “This is a great opportunity for our clients to apply and leverage sharp audience segments to TV buying. As an industry, we can be smarter with TV, where a giant portion of our clients’ media investment presently sits, and this partnership gets us there.”
“This is a great opportunity for us to continue our leadership position in the automation space by enabling data-driven buying practices on TV”, said Arun Kumar, Global President at Cadreon. “This is a client-oriented investment that delivers efficiencies on the buy-side and is an indicator of how we want to work with ad tech companies to solve problems and ultimately improve returns for our clients,” Kumar added.
The Interpublic Group of Companies, Inc. provides advertising and marketing services. The company operates in two segments, Integrated Agency Networks and Constituency Administration Group. It offers consumer advertising, digital marketing, communications planning and media buying, public relations, and specialized communications disciplines.
Shares of Zillow Group, Inc. (NASDAQ:Z), during its Wednesday’s current trading session gained 0.03%, and is now trading at $98.01.
Zillow Group, declared its pro forma and merged financial results for the quarter ended March 31, 2015.
Pro Forma First Quarter 2015 Financial Highlights
- Pro forma Revenue raised 35% to $162.5 million from $120.7 million in the first quarter of 2014. Pro forma Revenue not taking into account Market Leader Revenue raised 41% to $149.0 million from $105.5 million in the first quarter of 2014.
- Pro forma Marketplace Revenue raised 42% to $136.9 million from $96.3 million in the first quarter of 2014.
- Pro forma Real Estate Revenue grew 54% to $113.4 million from $73.5 million in the first quarter of 2014.
- Pro forma Mortgages Revenue grew 33% to $10 million from $7.5 million in the first quarter of 2014.
- Pro forma Market Leader Revenue reduced 11% to $13.6 million from $15.3 million in the first quarter of 2014.
- Pro forma Display Revenue raised 5% to $25.6 million from $24.5 million in the first quarter of 2014.
- Pro forma basic and diluted net loss per share was $0.31 in the first quarter of 2015 contrast to pro forma basic and diluted net loss per share of $0.42 in the same period last year.
- Pro forma net loss was $17.9 million in the first quarter of 2015 contrast to pro forma net loss of $23.8 million in the same period last year.
- Pro forma Adjusted EBITDA was $24.5 million in the first quarter of 2015, or 15% of pro forma Revenue, which was an enhance from $12.1 million in the first quarter of 2014, or 10% of pro forma Revenue.
Zillow Group, Inc. operates real estate and home-related information marketplaces on mobile and the Web in the United States. It offers a portfolio of brands and products to assist people find vital information about homes, and connect with local professionals.
Finally, Baxter International Inc. (NYSE:BAX), lost -0.58% Wednesday.
Today, Baxter International declared it has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau Finanziaria S.p.A. The acquisition further accelerates the innovation capabilities and the commercial presence of Baxter BioScience in growing oncology markets for rare and orphan diseases. The company gains the leading marketed biologic treatment Oncaspar, the investigational biologic calaspargase pegol, and an established oncology infrastructure with clinical and sales resources. The Oncaspar transaction is predictable to close in the third quarter. By mid-year, Baxter anticipates to establish the BioScience business as a separate, publicly traded, innovation-oriented biopharmaceutical company, Baxalta Incorporated.
Oncaspar is a first-line biologic used as part of a multi-agent chemotherapy regimen to treat acute lymphoblastic leukemia (ALL). It is presently marketed in the United States, Germany, Poland and certain other countries and has about USD $100 million in annual sales. ALL is a rapidly progressing cancer of the white blood cells responsible for more than 80 percent of childhood leukemia cases.
Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company’s BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; and biosurgery products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
